Merck And Co Inc Receivables Turnover Ratio (MRK), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Merck and Co Inc   (NYSE: MRK)
 

Merck And Co Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Merck And Co Inc 's ability to collect accounts receivable sequentially worsen to 5.47, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Merck And Co Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 67 days, from 66 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 347 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2470, from overall ranking in the first quarter 2026 at 2752.

What is Receivable Turnover Ratio?
What is Merck And Co Inc Selling?


What is Receivable Turnover Ratio?





MRK Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 6.06 % 13.16 % 14.57 % 6.49 % 1.75 %
Y / Y Revenue Change 5.07 % 4.87 % 4.97 % 3.72 % -1.9 %
Receivable Turnover Ratio (TTM) 5.47 5.49 5.59 5.71 5.74
MRK's Total Ranking # 2470 # 2752 # 2466 # 2471 # 2495
Accounts Receivable average collection period days 67 67 65 64 64
Seq. Receivable Change 2.9 % 3.69 % -2.85 % 2.31 % 9.79 %
Seq. Revenue Change 1.97 % -0.7 % -5.07 % 9.3 % 1.78 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 101
Healthcare Sector # 348
Overall Market # 2470

Receivable Turnover Ratio Statistics
High Average Low
7.37 6.05 5.45
(Sep. 30, 2006)   (Sep 30 2017)






Financial Statements
Merck And Co Inc 's Accounts Receivable $ 12,564 Millions Visit MRK's Balance sheet
Merck And Co Inc 's Sales TTM $ 66,569 Millions Visit MRK's Income Statement
Sources of MRK's Revenues Visit MRK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MRK's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MRK's Growth Rates MRK's Roa MRK's Inventory Turnover Ratio MRK's Dividend Comparisons
MRK's Profitability Ratios MRK's Roi MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Valuation Ratios MRK's Roe MRK's Financial Strength Ratios MRK's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Nexgel Inc   14.52 $ 11.810  Millions$ 0.813  Millions
China Pharma Holdings Inc  14.46 $ 3.914  Millions$ 0.271  Millions
Lftd Partners Inc   14.13 $ 35.335  Millions$ 2.500  Millions
Talkspace Inc   14.09 $ 246.631  Millions$ 17.506  Millions
Lifestance Health Group Inc   14.07 $ 1,584.834  Millions$ 112.665  Millions
Ataibeckley Inc   13.83 $ 4.473  Millions$ 0.324  Millions
Amneal Pharmaceuticals Inc   13.83 $ 3,117.474  Millions$ 225.492  Millions
Arvinas Inc   13.49 $ 316.700  Millions$ 23.475  Millions
Rosecliff Acquisition Corp I  13.43 $ 16.467  Millions$ 1.226  Millions
Corcept Therapeutics Inc  13.30 $ 830.813  Millions$ 62.477  Millions
Precipio inc   13.25 $ 27.198  Millions$ 2.052  Millions
Skinhealth Systems Inc   13.04 $ 289.224  Millions$ 22.179  Millions
Chemed Corporation  12.94 $ 2,595.001  Millions$ 200.565  Millions
Qhslab Inc   12.77 $ 3.017  Millions$ 0.236  Millions
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.82 $ 8.855  Millions$ 0.749  Millions
Marpai Inc  11.71 $ 16.635  Millions$ 1.420  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Nrc Health  11.35 $ 139.996  Millions$ 12.337  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Premier Air Charter Holdings Inc   10.66 $ 31.562  Millions$ 2.961  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Lifeloc Technologies Inc   10.48 $ 9.269  Millions$ 0.884  Millions
Irhythm Holdings Inc   10.32 $ 825.702  Millions$ 80.007  Millions
Immucell Corporation  10.29 $ 29.777  Millions$ 2.893  Millions
Addus Homecare Corp  10.23 $ 1,475.610  Millions$ 144.195  Millions

Date modified: 2026-09-05T07:03:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.